Literature DB >> 1348269

The concept of supersensitivity psychosis.

B Kirkpatrick1, L Alphs, R W Buchanan.   

Abstract

The hypothesis that chronic neuroleptic treatment may induce relapse in some schizophrenic patients has received considerable attention. This effect, usually called supersensitivity psychosis, has been attributed to neuroleptic-induced changes in mesolimbic or mesocortical dopaminergic receptors. However, research has not established that neuroleptics cause the proposed effect, and considerations of mechanism have not been separated from those of causation. The focus of research in this area should be the establishment or refutation of a causal relationship between chronic neuroleptic use and psychotic relapse.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348269     DOI: 10.1097/00005053-199204000-00009

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  9 in total

Review 1.  G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice.

Authors:  Laura M Bohn; Raul R Gainetdinov; Marc G Caron
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

2.  Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis.

Authors:  Shigenori Tadokoro; Naoe Okamura; Yoshimoto Sekine; Nobuhisa Kanahara; Kenji Hashimoto; Masaomi Iyo
Journal:  Schizophr Bull       Date:  2011-03-14       Impact factor: 9.306

Review 3.  Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia.

Authors:  Yasunori Oda; Nobuhisa Kanahara; Masaomi Iyo
Journal:  Int J Mol Sci       Date:  2015-12-17       Impact factor: 5.923

4.  Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.

Authors:  Masayuki Takase; Nobuhisa Kanahara; Yasunori Oda; Hiroshi Kimura; Hiroyuki Watanabe; Masaomi Iyo
Journal:  J Psychopharmacol       Date:  2015-03-03       Impact factor: 4.153

5.  On discontinuing treatment in schizophrenia: a clinical conundrum.

Authors:  Robin Emsley
Journal:  NPJ Schizophr       Date:  2017-01-12

Review 6.  Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia.

Authors:  Nobuhisa Kanahara; Hiroshi Kimura; Yasunori Oda; Fumiaki Ito; Masaomi Iyo
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

7.  Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia.

Authors:  Yasunori Oda; Nobuhisa Kanahara; Hiroshi Kimura; Hiroyuki Watanabe; Kenji Hashimoto; Masaomi Iyo
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-29       Impact factor: 2.570

Review 8.  Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms.

Authors:  Ming Li
Journal:  J Psychopharmacol       Date:  2016-07-01       Impact factor: 4.153

Review 9.  Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review.

Authors:  John Yin; Alasdair M Barr; Alfredo Ramos-Miguel; Ric M Procyshyn
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.